Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15005761Phase 4Recruiting
Phase 4, open-label trial of atorvastatin, rosuvastatin and pitavastatin in atherosclerotic disease (6 arms), sponsored by Second Department of Cadre Ward, General Hospital of Jinan Military Region. Primary endpoints: HDAC3 gene, blood glucose and 3 more. Started Jan 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15005761.